Sherry Chou
From Wikipedia, the free encyclopedia
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Brigham and Women's Hospital
Critical care
Stroke
Harvard Medical School
Sherry Hsiang-Yi Chou | |
|---|---|
| Alma mater | McGill University Beth Israel Deaconess Medical Center Massachusetts General Hospital Brigham and Women's Hospital |
| Known for | Neurology Critical care Stroke |
| Scientific career | |
| Institutions | University of Pittsburgh Harvard Medical School |
Sherry Hsiang-Yi Chou is a Canadian neurologist and an Associate Professor of Neurology and Chief of Neurocritical Care at the Northwestern University Feinberg School of Medicine and Northwestern Medicine. She is a Fellow of the Neurocritical Care Society and the Society of Critical Care Medicine. During the COVID-19 pandemic Chou assembled a worldwide team of physicians and scientists to better understand the neurological impacts of COVID-19, forming the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID).[1][2] The first report of this large, multicenter, multicontinent consortium found that neurological manifestations are present in 8 out of 10 adult patients hospitalized with COVID-19 and are associated with increased mortality.[3]
Chou studied mathematics and physics at McGill University. She remained there for her medical degree, which she completed in 2001.[4] Chou completed medical internship at Beth Israel Deaconess Medical Center and residency in Neurology followed by fellowship in stroke and neurocritical care at Massachusetts General Hospital and Brigham and Women's Hospital.[5] Chou completed a master's degree in clinical translational research at Harvard Medical School in 2009. Following completion of training Chou remained on faculty at Brigham and Women's Hospital, where Chou worked on numerous large clinical trials such as the Antihypertensive Treatment of Acute Cerebral Hemorrhage-II (ATACH-II) research protocol, which looked to identify the therapeutic benefit of intensive blood pressure treatment in intracerebral haemorrhage patients.[6] She worked at Brigham for several years, holding a simultaneous faculty position at the Harvard Medical School.
